Polifeprosan 20 Carmustine Implant
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Polifeprosan 20 Carmustine Implant Means in Everyday Medical Language
Polifeprosan 20 Carmustine Implant is a type of chemotherapy treatment made especially for certain brain tumors. It consists of small, thin wafers that contain the chemotherapy drug carmustine. During brain surgery, these wafers are placed directly into the area where the tumor was removed. The wafers have a special coating that dissolves slowly, releasing the drug gradually over time. This allows the chemotherapy to target cancer cells left behind after surgery while limiting exposure to the rest of the body.
Why the Concept Can Matter in Cancer Care
This implant is mainly used to treat aggressive brain tumors such as high-grade gliomas and glioblastoma multiforme. It can be used when the tumor is newly diagnosed or if glioblastoma has returned after previous treatment. Because the drug is delivered locally at the tumor site, patients may experience fewer side effects compared to traditional chemotherapy given through the bloodstream. The implant is usually part of a combined treatment approach that includes surgery to remove as much tumor as possible and radiation therapy to treat remaining cancer cells.
What a Patient Might See, Feel, Read, or Be Told When This Term Comes Up
Patients will not see or feel the wafer after surgery because it is placed inside the brain. The implant may be called Gliadel Wafer, carmustine implant, or polifeprosan 20 carmustine implant—these are different names for the same treatment. Information about the wafer may appear in surgical reports, treatment plans, or drug information resources. It is important to understand that having a Polifeprosan 20 Carmustine Implant is one part of a broader treatment plan and does not guarantee a cure.
Common Sources of Confusion and How to Read the Term in Context
The names Gliadel Wafer, carmustine implant, and polifeprosan 20 carmustine implant all refer to the same treatment. This implant is different from other forms of carmustine chemotherapy that are given through injections or infusions affecting the whole body. When you see these terms, it is best to ask your care team how they apply to your specific situation rather than assuming they mean the same for every patient.
Practical Questions a Patient Could Ask Their Care Team
Patients and caregivers may want to ask how the implant fits into their overall treatment plan, what side effects to watch for, and how it compares to other chemotherapy options. It is also helpful to discuss how the implant might affect recovery after surgery and what follow-up care will involve. Understanding these details can help patients feel more informed and involved in their care.
Safety and Next Steps
This information is meant to help patients understand what Polifeprosan 20 Carmustine Implant is and how it may be used in brain tumor treatment. It is not a substitute for medical advice. Each person’s situation is unique, so treatment decisions depend on many factors. Patients should talk with their doctors to learn how this treatment applies to their care and what to expect. If you or a loved one is facing a brain tumor diagnosis, asking about this implant can be a helpful step in understanding treatment options.
Sources
Public source information used for this glossary entry includes: